Legacy Capital Group California’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Sell
2,754
-1,336
-33% -$120K 0.09% 260
2025
Q4
$357K Sell
4,090
-1,266
-24% -$96.1K 0.09% 268
2025
Q3
$307K Sell
5,356
-1,140
-18% -$65.6K 0.08% 288
2025
Q2
$383K Buy
6,496
+930
+17% +$60.1K 0.11% 220
2025
Q1
$407K Buy
5,566
+691
+14% +$57.1K 0.14% 188
2024
Q4
$403K Buy
4,875
+641
+15% +$50.6K 0.12% 205
2024
Q3
$303K Buy
4,234
+1,221
+41% +$86.2K 0.1% 229
2024
Q2
$206K Buy
+3,013
New +$180K 0.07% 288

Other funds holding GMED

Legacy Capital Group California's GMED Position: Q1 2026 in Review

Legacy Capital Group California reduced its Globus Medical (GMED) stake by 33% in Q1 2026, selling an estimated $120K and leaving 2,754 shares worth $237K. The position accounts for 0.09% of the portfolio, ranked #260.

Legacy Capital Group California first reported a position in GMED in Q2 2024 and has held it in 8 quarters since. The position peaked at $407K in Q1 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Legacy Capital Group California held 2,754 shares of Globus Medical worth $237K as of Q1 2026.
  • Legacy Capital Group California sold 1,336 Globus Medical shares in Q1 2026, an estimated $120K.
  • Globus Medical made up 0.09% of Legacy Capital Group California's portfolio in Q1 2026, its #260 holding.
  • Legacy Capital Group California first reported a position in Globus Medical in Q2 2024 and has held it in 8 quarters since.
  • Legacy Capital Group California's Globus Medical position peaked at $407K in Q1 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Legacy Capital Group California's 13F filing for Q1 2026, filed 4 May 2026.